Anne Forand Selected Research

Heart Failure

1/2013

Plasma fibroblast growth factor 23 concentration is increased and predicts mortality in patients on the liver-transplant waiting list.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anne Forand Research Topics

Disease

3	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 11/2022 - 06/2020
2	Neuromuscular Diseases (Neuromuscular Disease) 11/2022 - 06/2020
2	Inflammation (Inflammations) 01/2022 - 12/2019
1	Muscular Diseases (Myopathy) 01/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2016
1	Insulin Resistance 01/2016
1	Anemia 01/2013
1	Chronic Renal Insufficiency 01/2013
1	Heart Failure 01/2013

Drug/Important Bio-Agent (IBA)

2	DystrophinIBA 11/2022 - 06/2020
2	Proteins (Proteins, Gene)FDA Link 11/2022 - 06/2020
1	CalciumIBA 01/2022
1	NAD+ Nucleosidase (NAD(P) Nucleosidase)IBA 01/2022
1	Messenger RNA (mRNA)IBA 12/2019
1	LipopolysaccharidesIBA 12/2019
1	Insulin (Novolin)FDA Link 01/2016
1	Dietary Fats (Dietary Fat)IBA 01/2016
1	Glucose (Dextrose)FDA LinkGeneric 01/2016
1	Fibroblast Growth Factor-23IBA 01/2013

Therapy/Procedure

1	Liver Transplantation 01/2013